KLONOPIN Safety Questions, KLONOPIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about KLONOPIN. Our extensive database of KLONOPIN adverse events and KLONOPIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about KLONOPIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




KLONOPIN Safety Reports

Total KLONOPIN reports: 57.
KLONOPIN FDA safety alerts: No.
Reported deaths: 8    Reported hospitalizations: 16.
Take KLONOPIN Side Effects Survey or Share Your KLONOPIN Story. KLONOPIN Usage.

Physician from UNITED STATES reported KLONOPIN problem on Dec 22, 2006. Male patient, 64 years of age, was diagnosed with anxiety, depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: gastric cancer, oesophageal disorder. KLONOPIN dosage: unknown. During the same period patient was treated with VALIUM, PAXIL, TOPROL, ASPIRIN, PRAVACHOL, COENZYME Q, VITAMIN NOS. Patient recovered.

KLONOPIN problem was reported by a Physician from UNITED STATES on Jan 03, 2007. Female patient, 35 years of age, was diagnosed with panic disorder, depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. KLONOPIN dosage: unknown. During the same period patient was treated with EFFEXOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Jan 27, 2007. Female patient, 51 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: amnesia, brain damage, personality change. KLONOPIN dosage: unknown. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2007. Male patient, 19 years of age, was diagnosed with anxiety and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: convulsion, suicide attempt. KLONOPIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Feb 20, 2007. Female patient, 40 years of age, weighting 150.0 lb, was diagnosed with anxiety, panic attack, post-traumatic stress disorder and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: speech disorder. KLONOPIN dosage: 1.0 MG ^AS NEEDED BASIS^. Patient recovered.

KLONOPIN problem was reported by a Physician from UNITED STATES on Feb 22, 2007. Female patient was diagnosed with panic disorder, anxiety, insomnia and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: amnesia, road traffic accident. KLONOPIN dosage: unknown. During the same period patient was treated with ETHANOL, AMBIEN, XANAX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Mar 02, 2007. Female patient, 35 years of age, was diagnosed with panic disorder, depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. KLONOPIN dosage: unknown. During the same period patient was treated with EFFEXOR. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Male patient was diagnosed with anxiety and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. KLONOPIN dosage: DOSING: 0.5 MG EVERY EVENING. During the same period patient was treated with VALIUM. Patient recovered.

Health Professional from UNITED STATES reported KLONOPIN problem on Mar 30, 2007. Female patient, 56 years of age, weighting 160.0 lb, was diagnosed with nervousness and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: anxiety, disorientation, hyperhidrosis, hypersensitivity, loss of employment, palpitations. KLONOPIN dosage: unknown. During the same period patient was treated with ALPRAZOLAM. Patient recovered.

KLONOPIN problem was reported by a Physician from UNITED STATES on Mar 30, 2007. Male patient, 33 years of age, was diagnosed with anxiety, depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: completed suicide. KLONOPIN dosage: unknown. During the same period patient was treated with CELEXA. Patient died on 02/20/2007.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Mar 12, 2007. Male patient was diagnosed with insomnia and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: amnesia, hallucination, road traffic accident, sleep walking. KLONOPIN dosage: unknown. During the same period patient was treated with RITALIN, FLEXERLL, AMITRYTYLINE, AMBIEN. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2007. Female patient, 15 years of age, was diagnosed with bipolar disorder and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: alcohol use, anaemia, euphoric mood, obsessive-compulsive disorder. KLONOPIN dosage: unknown. During the same period patient was treated with LAMICTAL, SEROQUEL, ZOLOFT, STRATTERA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on May 04, 2007. Female patient, 42 years of age, weighting 133.0 lb, was diagnosed with insomnia and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: emotional disorder, nightmare, sleep disorder. KLONOPIN dosage: 1 MG 1 AT NIGHT PO. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 10, 2007. Female patient, 78 years of age, weighting 128.0 lb, was diagnosed with osteoporosis and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiac valve vegetation, chills, endocarditis, muscle spasms, pyrexia, weight decreased. KLONOPIN dosage: unknown. During the same period patient was treated with AMITRIPTYLINE, SYNTHROID, FOSAMAX, PREVACID, FORTEO. Patient recovered.

Physician from UNITED STATES reported KLONOPIN problem on May 15, 2007. Male patient, 33 years of age, was diagnosed with anxiety, depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: completed suicide, gun shot wound. KLONOPIN dosage: unknown. During the same period patient was treated with CELEXA. Patient died on 02/20/2007.

KLONOPIN problem was reported by a Physician from UNITED STATES on May 30, 2007. Male patient, 33 years of age, was diagnosed with anxiety, depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: completed suicide. KLONOPIN dosage: unknown. During the same period patient was treated with CELEXA. Patient died on 02/20/2007.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on June 13, 2007. Female patient, 37 years of age, was diagnosed with epilepsy and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KLONOPIN dosage: unknown. During the same period patient was treated with TEGRETOL, FOLIC ACID. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2007. Female patient, 37 years of age, was diagnosed with epilepsy and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KLONOPIN dosage: unknown. During the same period patient was treated with TEGRETOL, FOLIC ACID. Patient recovered.

Physician from UNITED STATES reported KLONOPIN problem on June 08, 2007. Female patient, 26 years of age, was diagnosed with anxiety, psychotic disorder, parkinson's disease, major depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: depression, diabetes mellitus, intraocular pressure increased, myopia. KLONOPIN dosage: 2 MG, 3/D. During the same period patient was treated with RISPERDAL, ARTANE, PARLODEL, PLE VITAMIN, CYMBALTA. Patient was hospitalized. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Male patient, 63 years of age, weighting 178.0 lb, was diagnosed with panic attack and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: blepharospasm, dyspnoea, inner ear disorder, muscle contracture, tinnitus. KLONOPIN dosage: 1/4 MG ONCE PER/DAY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on May 23, 2006. Female patient, 52 years of age, was diagnosed with depression, eating disorder and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: convulsion, loss of consciousness. KLONOPIN dosage: unknown. During the same period patient was treated with WELLBUTRIN, GEODON, TRILEPTAL. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2006. Male patient, child 11 years of age, was diagnosed with epilepsy and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: convulsion, gait disturbance. KLONOPIN dosage: unknown. During the same period patient was treated with TOPAMAX, TEGRETOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Aug 07, 2006. Female patient, 70 years of age, weighting 149.9 lb, was diagnosed with insomnia and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: pneumonia. KLONOPIN dosage: unknown. Patient was hospitalized. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Female patient, 47 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: adverse event, overdose. KLONOPIN dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported KLONOPIN problem on July 27, 2006. Male patient was diagnosed with convulsion and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: anxiety, convulsion, dyskinesia. KLONOPIN dosage: unknown. During the same period patient was treated with NEURONTIN. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2007. Male patient, 36 years of age, was diagnosed with anxiety and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, diabetes mellitus non-insulin-dependent, hypertension, thyroid disorder, weight increased, weight loss poor. KLONOPIN dosage: unknown. During the same period patient was treated with ZOLOFT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on June 21, 2007. Male patient, 54 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: chest pain, thrombosis mesenteric vessel, tremor. KLONOPIN dosage: unknown. Patient recovered.

KLONOPIN problem was reported by a Physician from UNITED STATES on June 12, 2006. Female patient, 80 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: angle closure glaucoma. KLONOPIN dosage: unknown. During the same period patient was treated with EVISTA, ZOCOR, EFFEXOR, XALATAN. Patient recovered.

Pharmacist from UNITED STATES reported KLONOPIN problem on July 17, 2006. Female patient, 79 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: somnolence. KLONOPIN dosage: 2MG PO (DURATION: OTO). During the same period patient was treated with LITHIUM CARBONATE, REGLAN, CLONAZEPAM, COLACE, GLYCOLAX, COMBIVENT, GABAPENTIN, GENEBS. Patient was hospitalized. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2006. Female patient, weighting 147.9 lb, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: dissociative disorder. KLONOPIN dosage: unknown. During the same period patient was treated with AMBIEN. Patient recovered.

Pharmacist from UNITED STATES reported KLONOPIN problem on July 28, 2006. Female patient, 79 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: mental status changes, somnolence. KLONOPIN dosage: 2 MG PO OTO. During the same period patient was treated with LITHIUM, REGLAN, CLONAZEPAM, COLACE, GLYCOLAX, COMBIVENT, GABAPENTIN, GENEBS. Patient was hospitalized. Patient recovered.

KLONOPIN problem was reported by a Physician from UNITED STATES on July 24, 2006. Male patient, 53 years of age, weighting 179.9 lb, was diagnosed with insomnia related to another mental condition, arthritis and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, ejection fraction decreased. KLONOPIN dosage: unknown. During the same period patient was treated with CELEBREX. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported KLONOPIN problem on Aug 22, 2006. Female patient, 43 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: fatigue, somnolence. KLONOPIN dosage: 0.5 MG ONCE BID. Patient recovered.

KLONOPIN problem was reported by a Health Professional from UNITED STATES on Aug 24, 2006. Female patient, 54 years of age, weighting 130.0 lb, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: completed suicide. KLONOPIN dosage: unknown. Patient died.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Aug 21, 2006. Female patient, 54 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: completed suicide, suicide attempt. KLONOPIN dosage: unknown. Patient was hospitalized. Patient died on 06/28/2006.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2006. Male patient, weighting 165.0 lb, was diagnosed with anxiety, panic disorder and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, anger, anxiety, confusional state, hostility, panic attack, personality change. KLONOPIN dosage: 0.5 MG 3X -4X DAY ORALLY. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Sept 06, 2006. Male patient, 69 years of age, weighting 173.9 lb, was diagnosed with meniere's disease, hypothyroidism and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: convulsion, dizziness, muscle twitching. KLONOPIN dosage: unknown. During the same period patient was treated with SYNTHROID. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 12, 2006. Male patient, 33 years of age, weighting 205.0 lb, was diagnosed with anxiety and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: dizziness, headache, pharyngolaryngeal pain. KLONOPIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported KLONOPIN problem on Oct 05, 2006. Female patient, 41 years of age, weighting 248.0 lb, was diagnosed with bipolar disorder and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: affect lability, aggression, anxiety, hypomania, somnolence. KLONOPIN dosage: unknown. During the same period patient was treated with METHADONE, SEROQUEL, LITHIUM CARBONATE, PREVACID. Patient died on 04/05/2006.

KLONOPIN problem was reported by a Physician from UNITED STATES on Nov 01, 2006. Female patient, child 10 years of age, weighting 63.00 lb, was diagnosed with epilepsy, lennox-gastaut syndrome and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: irritability, screaming. KLONOPIN dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported KLONOPIN problem on Oct 31, 2006. Male patient, 33 years of age, weighting 315.0 lb, was diagnosed with anxiety, schizophrenia and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: cardiac valve disease, haemorrhage, hyperthermia. KLONOPIN dosage: unknown. During the same period patient was treated with RISPERIDONE. Patient was hospitalized. Patient died on 07/30/2006.

KLONOPIN problem was reported by a Physician from UNITED STATES on Sept 20, 2006. Female patient, 81 years of age, was diagnosed with anxiety, bipolar disorder, depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: aphasia, catatonia, depressed level of consciousness, depression, disorientation, dyspnoea, oral intake reduced, white blood cell count decreased. KLONOPIN dosage: 0.5 MG, TID. During the same period patient was treated with CLOZARIL, HALOPERIDOL USP, LITHIUM CARBONATE, CELEXA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Nov 03, 2006. Female patient was diagnosed with mania and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: blood thyroid stimulating hormone decreased, dependence, diabetes mellitus, muscle spasms, tremor, victim of crime, victim of sexual abuse. KLONOPIN dosage: unknown. Patient was hospitalized. Patient recovered.

KLONOPIN problem was reported by a Physician from UNITED STATES on Dec 01, 2006. Female patient, 35 years of age, was diagnosed with panic disorder, depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: optic neuropathy. KLONOPIN dosage: unknown. During the same period patient was treated with VENLAFAXINE. Patient recovered.

Physician from UNITED STATES reported KLONOPIN problem on Dec 01, 2006. Female patient, 35 years of age, was diagnosed with panic disorder, depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: optic neuropathy. KLONOPIN dosage: unknown. During the same period patient was treated with VENLAFAXINE. Patient recovered.

KLONOPIN problem was reported by a Physician from UNITED STATES on Aug 23, 2006. Female patient, 82 years of age, weighting 125.0 lb, was diagnosed with hypothyroidism and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: asthenia, balance disorder, clumsiness, dependence, dizziness, fall, headache, hyperhidrosis, somnolence. KLONOPIN dosage: unknown. During the same period patient was treated with CLONAZEPAM, LEVOXYL, MIRTAZAPINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Dec 14, 2006. Female patient, 41 years of age, weighting 130.0 lb, was diagnosed with neck pain and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, clumsiness, cognitive disorder, confusional state, constipation, convulsion, depression, diarrhoea, dizziness. KLONOPIN dosage: 1 MG 3X PO. Patient was hospitalized. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, 80 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: disturbance in social behaviour, hostility. KLONOPIN dosage: unknown. Patient died on 01/01/1986.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on July 27, 2007. Female patient, 49 years of age, weighting 123.0 lb, was diagnosed with post-traumatic stress disorder and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: myoclonus, respiratory disorder. KLONOPIN dosage: 2 MGS 4-5 TIMES A DAY PO. Patient recovered.

KLONOPIN problem was reported by a Pharmacist from UNITED STATES on July 24, 2007. Female patient, 45 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: dupuytren's contracture. KLONOPIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported KLONOPIN problem on Aug 07, 2007. Male patient, weighting 248.0 lb, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome. KLONOPIN dosage: unknown. During the same period patient was treated with HALDOL. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Female patient was diagnosed with major depression and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: rash. KLONOPIN dosage: 1 MG TWICE DAILY. Patient recovered.

Health Professional from UNITED STATES reported KLONOPIN problem on Sept 04, 2007. Female patient, 31 years of age, weighting 115.0 lb, was diagnosed with depression, post-traumatic stress disorder and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: agitation. KLONOPIN dosage: unknown. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Female patient, 42 years of age, was diagnosed with anxiety and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: anxiety, infection, lyme disease, sepsis, somatoform disorder, staphylococcal infection. KLONOPIN dosage: unknown. During the same period patient was treated with CLONAZEPAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Sept 05, 2007. Female patient, weighting 148.0 lb, was diagnosed with anxiety, gastric disorder and was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: anger, dizziness, feeling abnormal, headache, malaise, nausea, nephrolithiasis, night sweats. KLONOPIN dosage: 1 MG 3XDAILY. Patient recovered.

KLONOPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 06, 2007. Female patient, 57 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: delirium, hepatic enzyme increased, migraine, pain, panic reaction, skin wrinkling, tachycardia, urine analysis abnormal, vasculitis. KLONOPIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KLONOPIN problem on Sept 13, 2007. Female patient, 57 years of age, was treated with KLONOPIN. After drug was administered, patient experienced the following problems/side effects: delirium, fatigue, hepatic enzyme increased, malaise, migraine, pain, panic reaction, skin disorder, skin wrinkling. KLONOPIN dosage: unknown. Patient was hospitalized. Patient recovered.

Ask Our Patient Community about KLONOPIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert
RituximabThis drug has as active FDA Safety Alert
Rivastigmine tartrate
RizatriptanThis drug has as active FDA Safety Alert
RocephinThis drug has as active FDA Safety Alert (ceftriaxone)
Rofecoxib
RosuvastatinThis drug has as active FDA Safety Alert
Rozerem (ramelteon)

back to top

S
Sacrosidase
Salmeterol xinafoate

Sanctura (trospium)
Seconal (secobarbital)
Secobarbital
Selzentry
Sensipar (cinacalcet)
Serevent Diskus (salmeterol xinafoate)
Seroquel (quetiapine)
Sertaconazole
SertralineThis drug has as active FDA Safety Alert
Serzone